- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04427488
The Effect of Exercises Performed According to Circadian Rhythm in Type 2 Diabetes (Circadian)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
INTRODUCTION: Type 2 diabetes is a metabolic disease characterized by partial insulin deficiency or insulin resistance in peripheral tissue. Type 2 diabetes, which has a very high prevalence worldwide, is a socially serious health problem. Complications seen with the disease negatively affect human health. Physical activity and regular exercise are shown in the first place with pharmacological treatment and diet approaches in the treatment of Type 2 diabetes. Exercise has beneficial effects on the glycemic profile, such as decreased glycemic hemoglobin (HbA1c) level, increased maximum oxygen consumption (VO2max) and improved insulin sensitivity in diabetes patients. When the literature is examined, it is seen that exercise is also effective in improving metabolic health. Although the metabolic benefits of exercise have been shown, there is no study of which type of exercise is more beneficial in what time of day in individuals with Type 2 diabetes. Circadian rhythm plays an important role in clarifying this issue because the circadian rhythm is impaired in the glucose metabolism of individuals with type 2 diabetes.
AIM: The aim of this study is to evaluate the effectiveness of structured exercises given in accordance with the circadian rhythm of individuals with type 2 diabetes.
METHOD: 30 people with Type 2 diabetes in accordance with the criteria for inclusion in the Department of Endocrine and Metabolism Diseases of Medipol University Hospital in Istanbul will be included in this study. Individuals who have been diagnosed with Type 2 diabetes between the ages of 35-65, who have body mass index between 25 and 30, who have HbA1c value> 6.5%, who have fasting blood glucose>126 mg/dl, who have Type 2 diabetes between 5-10 years, who have inactive physical activity, who independently can walk and volunteer to exercise for at least 3 days a week will be included in our study. Type 1 diabetes individuals, diagnosed with Latent Autoimmune Diabetes in Adults (LADA), having diabetic Ketoacidosis coma, orthopedic or surgical problems to prevent walking and exercising, foot ulcers, individuals have any neurologıcal problem and individuals with cardiac, pulmonary or systematic diseases that will cause contraindications will not be included in the study. Blood sample evaluations, circadian rhythm evaluation, 6-minute walking test, 30-second sit to stand test, quality of life assessment with Ferrans&Powers Quality of Life Index of the individuals included will be carried out at the beginning of the study (T0) and at 6 (T1), 12 (T2) and 18 (T3) weeks after the study started Participants will be divided into two groups, morning (MC) and evening chronotypes (EC), according to their circadian rhythms. In both groups, there was a 6-week control period in which the participants continued to their routine treatment and did not perform any specific exercises. In the MC group, exercises were applied in the morning hours for the first 6 weeks and in the evening hours for the next 6 weeks. The EC exercises were applied in the evening hours for the first 6 weeks and in the morning hours for the next 6 weeks. A structured exercise program with aerobic and strengthening exercises was carried out in both groups for 3 days a week over 12 weeks. . Individuals were evaluated in terms of the blood test, functional capacity and quality of life at the baseline, 6 weeks before the exercise, 6 and 12 weeks after the exercises.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Istanbul, Turkey, 34820
- Istanbul Medipol University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Clinical diagnosis of Type 2 diabetes
- Between the ages of 35-65
- Body mass index between 25 and 30
- HbA1c value> 6.5%
- Fasting blood glucose>126 mg/dl
- Inactive physical activity level
- Who independently can walk and volunteer to exercise for at least 3 days a week
Exclusion Criteria:
- Clinical diagnosis of Type 1 diabetes
- Clinical diagnosis of Latent Autoimmune Diabetes in Adults (LADA)
- Having diabetic Ketoacidosis coma
- Orthopedic or surgical problems to prevent walking and exercising
- Foot ulcers
- Neurologıcal, cardiac, pulmonary or systematic diseases
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NON_RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Morning Chronotype (MC) Group
In the MC group, exercises were applied in the morning hours for the first 6 weeks and in the evening hours for the next 6 weeks.
|
Total of 12 weeks aerobic and strengthening exercises in different timing of the day.
|
EXPERIMENTAL: Evening Chronotype (EC) Group
The EC exercises were applied in the evening hours for the first 6 weeks and in the morning hours for the next 6 weeks
|
Total of 12 weeks aerobic and strengthening exercises in different timing of the day.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
HbA1c evaluation
Time Frame: 3 hours
|
Blood sample scores are changeable
|
3 hours
|
Fasting glucose evaluation
Time Frame: 3 hours
|
Blood sample are changeable
|
3 hours
|
HDL (high density lipoprotein) evaluation
Time Frame: 3 hours
|
Blood sample are changeable
|
3 hours
|
LDL (low density lipoprotein) evaluation
Time Frame: 3 hours
|
Blood sample are changeable
|
3 hours
|
Total cholesterol evaluation
Time Frame: 3 hours
|
Blood sample are changeable
|
3 hours
|
Circadian Rhythm Evaluation with Morningness Eveningness Questionnaire
Time Frame: 10 minutes
|
Scores can range from 16-86.
Scores of 41 and below indicate "evening types".
Scores of 59 and above indicate "morning types".
Scores between 42 and 58 indicate "intermediate types" in Morningness Eveningness Questionnaire
|
10 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
6-minute walking test
Time Frame: 10 minutes
|
An increase in the distance walked indicates improvement in basic mobility.
|
10 minutes
|
30-second sit to stand test
Time Frame: 10 minutes
|
The wide variety of ability levels indicates with high scores
|
10 minutes
|
Ferrans&Powers Quality of Life
Time Frame: 10 minutes
|
High scores indicates high Quality of life in individuals with diabetes
|
10 minutes
|
Collaborators and Investigators
Publications and helpful links
General Publications
- Savikj M, Gabriel BM, Alm PS, Smith J, Caidahl K, Bjornholm M, Fritz T, Krook A, Zierath JR, Wallberg-Henriksson H. Afternoon exercise is more efficacious than morning exercise at improving blood glucose levels in individuals with type 2 diabetes: a randomised crossover trial. Diabetologia. 2019 Feb;62(2):233-237. doi: 10.1007/s00125-018-4767-z. Epub 2018 Nov 13.
- Menek MY, Budak M. Effect of exercises according to the circadian rhythm in type 2 diabetes: Parallel-group, single-blind, crossover study. Nutr Metab Cardiovasc Dis. 2022 Jul;32(7):1742-1752. doi: 10.1016/j.numecd.2022.04.017. Epub 2022 Apr 29.
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- merveymz
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 2 Diabetes
-
Antonio Di MauroCompletedType-2 DiabetesItaly
-
DiaMedica Therapeutics IncCompletedDiabetes Type 2Netherlands
-
RenJi HospitalUnknownType 2 Diabetes.China
-
University of Erlangen-Nürnberg Medical SchoolCompletedType 2-diabetesGermany
-
Chengdu Brilliant Pharmaceutical Co., Ltd.Not yet recruitingType 2 Diabetes Mellitus
-
Nanjing First Hospital, Nanjing Medical UniversityRecruitingType 2 Diabetes MellitusChina
-
Xiangya Hospital of Central South UniversityRecruitingType 2 Diabetes MellitusChina
-
University of Alabama at BirminghamCompletedType 2 Diabetes MellitusUnited States
-
Imperial College LondonAstraZeneca; Huma; North West London Collaboration of CCGs (NWL CCGs); Imperial...CompletedType 2 Diabetes MellitusUnited Kingdom
-
Universiti Sains MalaysiaCompleted
Clinical Trials on Morning Chronotype group
-
Koç UniversityMarmara UniversityCompletedType1diabetes | Sleep | ChronotypeTurkey
-
University of Nevada, Las VegasCompletedMigraine DisordersUnited States
-
Universidad Católica San Antonio de MurciaHospital Universitario Virgen de la ArrixacaCompleted
-
Rush University Medical CenterCompleted
-
Ulsan University HospitalMinistry of Health & Welfare, KoreaCompletedArthroplasty, Replacement, Knee | RoboticsKorea, Republic of
-
Rutgers, The State University of New JerseyNot yet recruiting
-
The University of Texas Medical Branch, GalvestonNot yet recruitingStroke | Healthy VolunteersUnited States
-
Rutgers, The State University of New JerseyNoom Inc.RecruitingDiabetes Mellitus, Type 2 | Metabolic SyndromeUnited States
-
Rush University Medical CenterRecruitingSleep | Circadian Rhythm | Adolescence | Chronobiology | LightUnited States
-
Applied CognitionUniversity of Florida HealthCompleted